January 28, 2025

FDA Approves Enhertu for Metastatic, HR-Positive, HER2-Low or -Ultralow Breast Cancer

Enhertu, a HER2-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration for pretreated patients with metastatic HR-positive, HER2-low or HER2-ultralow breast cancer based on results from the DESTINY-Breast06 trial.

Conexiant

January 24, 2025

Sex and Age Influence Long COVID Risk

"These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID," wrote the study's authors.

Conexiant

January 23, 2025

Sjögren’s Disease: Impact on Sexual Health

Explore the link between Sjögren’s disease, sexual dysfunction, and depression through an in-depth analysis of patient-reported outcomes.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 13, 2025

Boosting Primary Care: Medical School Strategies

"It’s not the medical schools that are the problem; it’s the job. The job is too toxic.”

KFF Health News

January 06, 2025

Alcohol Hepatitis: Why Females Face Higher Risks

Study reveals rising hepatitis rates in young adults, with females facing greater risks of cirrhosis and liver-related death.

Conexiant

January 06, 2025

Menopause Timing and CVD: New Findings

New research links early menopause to increased cardiovascular disease risk.

Conexiant

May 08, 2024

ObGyn Harassment Prevalence Exposed in Revealing Review

Discover key insights from a systematic review on harassment among ObGyn health care professionals.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant